Home

PB Ratio of Concord Biotech Ltd

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PB Ratio

10.1

Last updated on: Jul 02, 2025

Key Highlights

  • The latest PB Ratio of Concord Biotech Ltd is 10.1.
  • The PB ratio of the Concord Biotech Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Concord Biotech Ltd changed from 10.4 on March 2024 to 10.4 on March 2024 . This represents a CAGR of 0.00% over 1 years.

Historical P/B Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

Market Cap

18,384 Cr

EPS

35.5

P/E Ratio (TTM)

49.5

P/B Ratio (TTM)

10.1

Day’s High

0.0

Day’s Low

0.0

DTE

0.0

ROE

20.5

52 Week High

2658.0

52 Week Low

0.0

ROCE

27.3

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Jul 20251757.35
01 Jul 20251797.2
30 Jun 20251848.85
27 Jun 20251825.15
26 Jun 20251797.15
25 Jun 20251814.05
24 Jun 20251780.75
23 Jun 20251822.5
20 Jun 20251840.05
19 Jun 20251968.55

SWOT Analysis Of Concord Biotech Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Concord Biotech Ltd

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Concord Biotech Ltd Explained

18384

Market cap

173

Book Value per Share

10.1X

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Concord Biotech Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Concord Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Biotech Ltd News Hub

Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against

Read more

09 Aug 24

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst

Read more

29 Aug 24

Concord Biotech to announce Quarterly Result

Concord Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2025. Powered

Read more

24 May 25

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow

Read more

06 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for PB Ratio of Concord Biotech Ltd

What is the PB ratio of Concord Biotech Ltd?

The current PB ratio of Concord Biotech Ltd is 10.14. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Concord Biotech Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Concord Biotech Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Concord Biotech Ltd calculated?

The PB ratio of Concord Biotech Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Concord Biotech Ltd?

A high PB ratio suggests that Concord Biotech Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Concord Biotech Ltd?

A low PB ratio of Concord Biotech Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Concord Biotech Ltd PB Ratio change over time?

Yes, the PB ratio of Concord Biotech Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions